EMEA-003112-PIP01-21-M01 - paediatric investigation plan
Donidalorsen
PIPHuman
Key facts
- Active Substance
- Donidalorsen
- Therapeutic area
- Congenital, familial and genetic disorders
- Decision number
- P/0246/2024
- PIP number
- EMEA-003112-PIP01-21-M01
- Pharmaceutical form(s)
- Solution for injection
- Condition(s) / indication(s)
- Treatment of hereditary angioedema
- Route(s) of administration
- Subcutaneous use
- Contact for public enquiries
Otsuka Pharmaceutical Netherlands B.V.
Email: paediatrics-info@otsuka-europe.com
Tel.: +49 691700860- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date